CPHRF (Cipher Pharmaceuticals) Float Percentage Of Total Shares Outstanding: 0.00% (As of Jul. 02, 2026)


CPHRF Cipher Pharmaceuticals Inc CPHRF
96 GF Score
Price $11.77
GF Value $12.30
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Cipher Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Cipher Pharmaceuticals CPHRF +1.60% 96 Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 02, 2026. GuruFocus rates CPHRF with a GF Score™ of 96/100 and a GF Value™ of $12.30 (Fairly Valued). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cipher Pharmaceuticals's float shares is 0.00 Mil. Cipher Pharmaceuticals's total shares outstanding is 25.39 Mil. Cipher Pharmaceuticals's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cipher Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cipher Pharmaceuticals's Institutional Ownership is 4.60%.

CPHRF
96GF Score
Cipher Pharmaceuticals Inc CPHRF
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cipher Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cipher Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/25.39
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 0.00% mean?
Cipher Pharmaceuticals (CPHRF) has a Float Percentage Of Total Shares Outstanding of 0.00% as of Jul. 02, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Cipher Pharmaceuticals and its competitors.
Is Cipher Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
Cipher Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 0.00%. Overall, Cipher Pharmaceuticals has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cipher Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to ZTS and UTHR?
Cipher Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Drug Manufacturers company?
A good Float Percentage Of Total Shares Outstanding depends on the Drug Manufacturers industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Cipher Pharmaceuticals and its competitors. Cipher Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cipher Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Cipher Pharmaceuticals (CPHRF) is currently considered Fairly Valued. The stock's GF Value™ is $12.30, compared to a current price of $11.77 — trading 4.3% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 0.00%. Cipher Pharmaceuticals' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Cipher Pharmaceuticals (CPHRF), the current Float Percentage Of Total Shares Outstanding is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cipher Pharmaceuticals (CPHRF) Overvalued in 2026?

Based on GuruFocus' analysis, Cipher Pharmaceuticals stock appears to be undervalued. The current stock price of $11.77 is trading 4.3% below its estimated GF Value™ of $12.30. GuruFocus considers Cipher Pharmaceuticals to be Fairly Valued.

Key valuation signals for CPHRF:

  • Float Percentage Of Total Shares Outstanding: 0.00%
  • GF Value™: $12.30 vs. price of $11.77 (4.3% below fair value)
  • GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the CPHRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Cipher Pharmaceuticals Business Description

Other Exchanges PHE:GermanyCPH:Canada
Address 5750 Explorer Drive, Suite 404, Mississauga, ON, CAN, L4W 0A9
Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital Acute Care Products, specialty medicines, and Out-Licensed Products, among others. The company's geographical operational areas include Canada and the United States.
96GF Score

Get the complete analysis for CPHRF

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.77
Price
$12.30
GF Value